1. Market Research
Strategic Evaluation of Precision Medicine: Country Analysis for Emerging Opportunities

Strategic Evaluation of Precision Medicine: Country Analysis for Emerging Opportunities

  • August 2018
  • 51 pages
  • ID: 5563105
  • Format: PDF
  • By BIS Research

Summary

Table of Contents

Strategic Evaluation of Precision Medicine Market by BIS Research

This strategic report provides a multidimensional view of the strategic evolution in the field of precision medicine.The purpose of the study is to gain a holistic view of the strategic outline of precision medicine market in terms of various factors influencing it such as recent trends, technological advancements, reimbursement scenario, and national level initiatives across the globe.

The scope of this report is centred upon conducting a detailed study of the region-specific market penetration strategies, best R&D practices across the globe, potential impact of precision medicine, and understanding the focus of eminent stakeholders contributing in augmenting the growth of precision medicine market.

Key questions answered in the report:
• How does the emergence of precision medicine approach is remodelling the “One-Size-Fits-All” theory to individually-tailored therapy?
• What are the key regional strategies which have been followed in North America, Europe, and Asia-Pacific for penetration and implementation of precision medicine?
• What are the best practices in the field of precision medicine across the world?
• What is the role of key stakeholders in aligning the fortune of precision medicine?
• What are the major market drivers, challenges, and opportunities in the global precision medicine market?
• What are the persuasive market entry strategies for diagnostics, pharma & biotech, and healthcare IT companies to capitalize on precision medicine?
• What is the plausible market penetration strategy for the precision medicine market?
• What are the current value assessment frameworks followed in the field of precision medicine?
• What are the potential societal value for precision medicine?
• What is the propitious go-to-market strategy to succeed in the field of precision medicine?

Executive Summary
Precision medicine holds immense potential to restructure the healthcare industry.This multi-faceted approach to patient care allows healthcare providers to avoid adverse drug reactions (ADR), focus efforts on prevention and earlier intervention, and, most importantly, improve the quality of life.

The growth of the precision medicine market over the last few years has been monumental.Novel technologies are rapidly becoming approved expanding the arsenal of tools accessible to support the development and adoption of precision medicine solutions over “one-size-fits-all” therapies.

Through precision medicine a paradigm shift has been promised by eliminating the uncertainty of trial and error method of medications. Inefficiencies such as false-positive and false-negative results, over or under medication, and ineffective treatments have been reduced at a greater extent by the implementation of patient-centric diagnosis, thus removing the requirement of guesswork by transforming the treatment from experience-based approach to evidence-based strategy.

The precision medicine market, cumulative of biopharmaceuticals, diagnostics, and information technology, is fragmented in nature due to the involvement of numerous global as well as regional players in this industry.Also, many regulatory bodies and consortiums are playing vital roles in regulating and standardizing the precision medicine market.

In 2017, the global precision medicine market accounted for $48.9 billion, which is expected to reach ~$70 billion by 2020 with effective implementation of several novel technologies. Further, several initiatives have been undertaken for significant growth of precision medicine in North America, Europe, and Asia-Pacific. The global precision medicine market is dominated by the North America region with a value of $25.6 billion in 2017. The promotion of big data analytics to support the process of genomic and clinical data collection, storage, and analysis is leading to increasing integration of IT into the healthcare sector, subsequently enhancing the adoption of precision medicine tools. However, the Asia-Pacific region has been witnessing tremendous growth in the precision medicine technology and is expected to grow significantly at a CAGR of approximately 15.09% in the next 10 years.

The purpose of the study is to gain a holistic view of the strategic outline of precision medicine market in terms of various factors influencing the market such as recent trends, technological advancements, reimbursement scenario, and national-level initiatives across the globe. The scope of this report is centered upon conducting a detailed study of the region-specific market penetration strategies, best R&D practices across the globe, potential impact of precision medicine, and understanding the focus of eminent stakeholders who are contributing in augmenting the growth of the precision medicine market.

Additionally, the study incorporates the impact of various government initiatives focused on precision medicine including Small Business Technology Transfer (STTR), Cancer Diagnosis Program, Cancer Imaging Program, Cancer Therapy Evaluation Program (CTEP), Cancer Moonshot 2020, and S4S Program, among others.These initiatives have introduced a new module of patient-centric research to provide new tools, technologies, and therapies to clinicians.

Moreover, initiatives taken in Asia-Pacific region such as GenomeAsia 100K are expected to generate a medical grade Asian reference genome to further improvise precision medicine research.

Further, the strategic evaluation of precision medicine comprehends R&D investments, which have approximately doubled during the past five years and are expected to increase by 30% during the next three years.Approximately 69% of drug development during the ensuing five years is predicted to be driven by personalized medicine.

Precision medicine targets a smaller subpopulation of patients for a specific drug, but at the same time the healthcare industry demands the drug price to be affordable to all the patients.Therefore, it is very important to strategize and co-develop drug-diagnostic pairs in order to leverage on each other’s technologies and expertise for offering advanced, cost-effective, and at the same time accurate diagnosis.

Presently, several pharma and bio-pharma companies are struggling with the challenge to launch new targeted medicines and their respective companion diagnostics parallelly, in order to target both the drug and diagnostic markets at a time, while taking lead in shaping the precision medicine future.In order to tailor each patient’s therapy according to the need, the transformation of the current mind-set and approach to discovery, translation, validation, regulation, and commercialization is highly essential.

Therefore, the research study incorporates the strategic evolution in the field of precision medicine to disseminate knowledge and understanding of the role of factors such as up-front investment, access to medical big data, efficient analytical capabilities, and accurate diagnostic technologies. The research study also incorporates the immense importance of the aforementioned factors to be successful in the field of precision medicine.

Countries Covered
• North America
• Europe
• Asia-Pacific

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
10% Off

($3000)

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Global Anomaly Detection Industry

Global Anomaly Detection Industry

  • $ 4950
  • October 2019

Anomaly Detection market worldwide is projected to grow by US$4.6 Billion, driven by a compounded growth of 16.8%. Services, one of the segments analyzed and sized in this study, displays the potential ...

Global Data Wrangling Industry

Global Data Wrangling Industry

  • $ 4950
  • October 2019

Data Wrangling market worldwide is projected to grow by US$3.3 Billion, driven by a compounded growth of 20.4%. Tools, one of the segments analyzed and sized in this study, displays the potential to grow ...

Big Data in E-commerce: Global Markets

Big Data in E-commerce: Global Markets

  • $ 5500
  • December 2019

Report Scope:This report includes market estimates and forecasts of big data implementation in the E-commerce industry at global, regional and country levels. It also highlights the ongoing trends and ...


ref:plp2018

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on